✦ LIBER ✦

No Increase in Adverse Events During Aliskiren Use Among Ontario Patients Receiving Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers

✍ Scribed by Gilbert, Cameron J.; Gomes, Tara; Mamdani, Muhammad M.; Hellings, Chelsea; Yao, Zhan; Garg, Amit X.; Wald, Ron; Harel, Ziv; Juurlink, David N.

Book ID: 123058507
Publisher: Pulsus Group Inc
Year: 2013
Tongue: English
Weight: 268 KB
Volume: 29
Category: Article
ISSN: 0828-282X
DOI: 10.1016/j.cjca.2013.02.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of aliskiren on the fibrinolytic

Effects of aliskiren on the fibrinolytic system in patients with coronary artery disease receiving angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor blocker

✍ Ken Ishibashi, Satoshi Kurisu, Yasuko Kato, Naoya Mitsuba… 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 183 KB

Does aspirin use adversely influence int

Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Findings from Organized Program to Facilitate Life-Saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)

✍ Phillip D. Levy; Deepa Nandyal; Robert D. Welch; Jie Lena Sun; Karen Pieper; Jal 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 540 KB